PMHNP Practice Authority in Alabama: Independence, Physician Agreements and Schedule II
Alabama approves psychiatric nurse practitioners as Certified Registered Nurse Practitioners through the Board of Nursing and the Board of Medical Examiners, and every CRNP practises under a collaborative practice agreement with a physician — AANP classes Alabama as reduced.
The limit for psychiatric practice: the Qualified Alabama Controlled Substances Certificate covers Schedules III to V only, so an Alabama PMHNP cannot prescribe Schedule II ADHD stimulants.
Controlled-substance prescribing waits on twelve months of collaborative practice, and a new CRNP's physician must be present for 10% of hours the first two years; patient-home, ADPH-licensed and ADMH-certified facility hours excepted.
Verify before you rely on this
At a glance
Certified Registered Nurse Practitioner (CRNP).
A pre-certification applicant may use the designation Graduate Registered Nurse Practitioner.
The Alabama Board of Nursing, which shares authority with the Alabama Board of Medical Examiners; the collaborative practice and controlled-substance (QACSC) rules are Board of Medical Examiners rules.
Reduced, per AANP's State Practice Environment map (updated 05/2026).
AANP's label, not a legal category.
The rules read set no route to independence: collaboration is career-long.
Inside it, two gates: 10% physician presence for a CRNP's first two years (4,000 hours) — patient-home and ADPH/ADMH-facility hours exempt — and twelve months of collaborative practice before the QACSC.
A written standard protocol signed by both, with a formulary and a quality-assurance plan, on file with both boards; quarterly meetings past two years (4,000 hours), remote-site visits twice annually, quarterly quality assurance.
No physician ratio cap was found in the rules read.
No. A QACSC covers Schedules III-V only, so Schedule II ADHD stimulants are off-limits.
A CRNP may administer a Schedule II ordered, prescribed or dispensed by a collaborating or covering physician.
Prescribable under the QACSC, within the drug type, dosage, quantity and refill limits the approved protocol sets; no day-supply cap is stated in the rules read.
Not enacted in Alabama.
The compact is not in effect anywhere: it needs seven states and five had enacted it as of September 2026.
The Alabama credential ladder
- Graduate Registered Nurse Practitioner (provisional approval)Pre-licensure
An Alabama-licensed RN who meets the requirements of rr.
610-X-5-.03 and .06 except national certification and has applied for initial certification may be granted provisional approval, limited to the Joint Committee-approved standard protocol and formulary — it does not include the additional skills of r.
610-X-5-.11 or drugs flagged "Restrictions" in the formulary.
Practice is under the on-site supervision of an approved CRNP or licensed physician, with one hundred percent review of patient cases by the collaborating physician, for a maximum of six months; it expires immediately on Board of Nursing approval notification or on notification of failing the certification exam.
- Certified Registered Nurse Practitioner(CRNP)Other
The approval to practise the two boards grant.
Prescribing is not automatic with it: prescriptive authority for legend drugs is granted inside collaborative practice with a physician, within the standard protocol and formulary both boards approve.
- CRNP holding a Qualified Alabama Controlled Substances Registration Certificate(QACSC)Other
The Board of Medical Examiners registration that adds controlled-substance prescribing, limited to Schedules III, IV and V; obtained annually for each approved collaborative practice agreement.
Reduced: prescriptive authority exists only inside collaborative practice
AANP's State Practice Environment map (updated 05/2026) puts Alabama in its reduced tier.
The label is AANP's advocacy classification; the legal facts behind it sit in the two boards' rules.
The Board of Nursing approves the CRNP, but prescriptive authority exists only inside collaborative practice: the nursing rule grants it to CRNPs engaged in collaborative practice with physicians, and the Board of Medical Examiners rule requires the collaborating physician to provide professional medical oversight and direction.
Legend-drug formularies are recommended by the Joint Committee of the two boards and adopted by both boards, and the collaborative-practice and QACSC rules are Board of Medical Examiners rules.
For what AANP’s full, reduced and restricted tiers mean, see can a PMHNP practice independently?
“Certified registered nurse practitioners engaged in collaborative practice with physicians may be granted prescriptive authority upon submission of evidence of completion of an academic course in pharmacology or evidence of integration of pharmacology theory and clinical application in the certified registered nurse practitioner curriculum.”
No route out: collaboration is career-long, with two experience gates
The rules read set no hours-or-years threshold after which a CRNP stops needing the collaborating physician.
Two experience gates sit inside the collaboration, doing different jobs.
The presence gate: for a CRNP with less than two years (4,000 hours) of collaborative practice experience — measured since initial certification, or in the collaborating physician's practice specialty — the physician must be present for not less than 10% of the CRNP's scheduled hours in the approved practice site, so a PMHNP joining a physician in a new specialty counts as new.
Scheduled hours in patient homes, in Alabama Department of Public Health-licensed or Alabama Department of Mental Health-certified facilities, and under specified limited protocols are not subject to the presence minimum.
The prescribing gate: the QACSC requires a minimum of twelve (12) months of active clinical practice under one or more approved collaborative practice agreements, and temporary or provisional approval time does not count toward it — a new graduate's first year is legend-drug-only.
Past two years (4,000 hours), the rule's stated physician duty becomes meetings no less than quarterly.
“Be present for not less than ten percent (10%) of the CRNP's scheduled hours in an approved practice site with a CRNP who has less than two (2) years (4,000 hours) of collaborative practice experience”
The standard protocol: what it contains and who can sign it
The written standard protocol is the agreement: specific to the CRNP's and the physician's specialty practice areas, signed by both, and on file with both boards.
It must include a formulary of drugs, devices, treatments, tests and procedures and a quality-assurance plan covering a meaningful sample of medical records plus all adverse outcomes — the rules set no fixed chart-review percentage.
Physician duties include remote-site visits no less than twice annually, quarterly quality assurance with each CRNP, and documentation kept for the collaboration plus three years; when working in the same facility as the CRNP, the physician has no additional requirement for documentation of on-site collaboration.
A collaborating physician needs an unrestricted Alabama medical licence and an experience floor — three years of practice, or one year plus specialty-board certification, or one year with a hospital-limited site — waivable by the Board of Medical Examiners.
A covering physician must be pre-approved by the Board of Medical Examiners and serves up to sixty (60) days after an unanticipated permanent absence.
No cap on CRNPs per physician appears in the rules read.
For who signs these agreements and what they cost, see PMHNP collaborative practice agreements.
“Specify a plan for quality assurance management with defined quality outcome measures for evaluation of the clinical practice of the certified registered nurse practitioner and include review of a meaningful sample of medical records plus all adverse outcomes.”
Schedule II is off the table: the QACSC covers Schedules III-V only
The rule that decides psychiatric prescribing: a QACSC is limited to Schedules III, IV and V.
Schedule I and II controlled substances cannot be prescribed, administered, authorized for administration or dispensed under one — the only exception is administering a drug the collaborating or covering physician has ordered, prescribed or dispensed.
An outpatient Alabama PMHNP cannot prescribe Schedule II ADHD stimulants.
The certificate: issued by the Board of Medical Examiners and obtained annually for each approved collaborative practice agreement.
Eligibility needs twelve months of approved collaborative practice, eight hours of controlled-substance prescribing instruction plus four hours of advanced pharmacology within the year before applying, and a collaborating physician holding a QACSC.
Renewal is annual by December 31 — $60, or $110 to apply — with four hours of controlled-substance continuing education every two years plus state prescription-monitoring and DEA registrations.
Prescribing to self, spouse, child or parent is barred, and if the collaborating physician's Alabama Controlled Substances Certificate becomes inactive, revoked, suspended, restricted or placed on probation, the CRNP's QACSC is administratively terminated by operation of law.
For the federal DEA rules on prescribing controlled substances by telehealth, see prescribing controlled substances by telehealth.
“A CRNP or CNM shall not use the authority of his or her QACSC to prescribe, administer, authorize for administration, or dispense any controlled substance enumerated in Schedule I or Schedule II; however, a CRNP or CNM may administer a Schedule II controlled substance which has been ordered, prescribed or dispensed by a collaborating or covering physician.”
The protocol sets the drug list; the DEA registration does not widen it
The CRNP's defined functions run from comprehensive evaluation and formulating a working diagnosis to prescribing, administering and providing therapeutic measures, all with physician collaboration and within the standard protocol.
Legend drugs must appear in the formulary the Joint Committee recommends and both boards adopt, and the drug type, dosage, quantity and refills are authorized in the approved protocol; off-label prescribing is permitted only when it is within the current standard of care, supported by evidence-based research, and approved by the collaborating physician and entered into the patient record.
On top of the state layer: the DEA registers the PMHNP as a mid-level practitioner, and that registration covers only what Alabama allows — a DEA form listing Schedules II to V does not widen the QACSC's III-V limit.
The DEA and HHS telemedicine flexibilities, extended through December 31, 2026, lift no Alabama rule, and Alabama's collaborative rules deem services to occur where the patient is located, with all parties bound to Alabama law for Alabama patients.
For how an FNP moves into psychiatric practice, see FNP to PMHNP.
APRN Compact: not enacted in Alabama, not in effect anywhere
Alabama has not enacted the APRN Compact.
The compact comes into effect only once seven states enact it, and five had as of September 2026 — Delaware, North Dakota, South Dakota, Utah and Wyoming — so no APRN holds a multistate APRN licence today.
The Nurse Licensure Compact is an RN compact (43 jurisdictions) and confers no nurse practitioner authority in another state.
To practise as a PMHNP in Alabama you need Alabama approval as a CRNP, a collaborative practice agreement and, for controlled substances, a QACSC.
2023-2024: QACSC amendments and a new physician CME requirement
The QACSC rules moved recently: r.
540-X-18-.07, the rule limiting a CRNP to Schedules III-V, was amended effective February 13, 2023 and September 14, 2023, and r.
540-X-18-.02, the general QACSC requirements, effective December 15, 2023.
The bigger operational change lands on physicians: since January 1, 2024, every collaborating physician must obtain Board of Medical Examiners continuing education on the collaborative practice rules every forty-eight months following commencement, and the qualification rule requires that education not more than forty-eight months before or within twelve months after commencing a collaboration.
Check both boards before assuming nothing has moved since.
“Effective January 1, 2024, all collaborating physicians shall obtain continuing medical education prescribed by the Board of Medical Examiners regarding the rules and statutes governing collaborative practice in Alabama every forty-eight months (48) following commencement of the collaborative practice.”
What This Page Does — and Doesn’t — Cover
This page summarizes the Alabama statute, rules, board pages and other documents cited above, as read for this state-by-state PMHNP practice authority series, current as of September 2026.
It does not list application forms, fees beyond those cited above, or processing times, and it is not a substitute for the instructions the Alabama Board of Nursing (with the Alabama Board of Medical Examiners) publishes.
Hour totals, exams and supervision rules change by statute and by board rule; for how the PMHNP and psychiatrist roles compare, see PMHNP vs psychiatrist.
Confirm every requirement with the Alabama Board of Nursing (with the Alabama Board of Medical Examiners) before you count hours, register for an exam or apply — and before you take one of the psychiatric nurse practitioner jobs in Alabama that asks for it.
Frequently Asked Questions
Can a PMHNP practice independently in Alabama?
No. Alabama CRNPs practise and prescribe under a collaborative practice agreement with a physician for their whole career, and the rules read offer no hours or years route out of it.
AANP classes Alabama as reduced.
The experience rules change what the collaboration demands — 10% physician presence in the first two years (patient-home, ADPH-licensed and ADMH-certified facility hours exempt), quarterly meetings after — but never end it.
Confirm your situation with the Alabama Board of Nursing and the Board of Medical Examiners.
Can an Alabama PMHNP prescribe Schedule II ADHD stimulants?
No. The Qualified Alabama Controlled Substances Registration Certificate limits a CRNP to Schedules III, IV and V, and the rule says a CRNP shall not prescribe, administer, authorize for administration or dispense any Schedule I or II controlled substance.
A CRNP may administer a Schedule II drug that a collaborating or covering physician has ordered, prescribed or dispensed.
A DEA registration does not widen the Alabama limit.
Confirm with the Board of Medical Examiners.
When can a new graduate start prescribing controlled substances in Alabama?
Not immediately.
A QACSC applicant must document a minimum of twelve months of active clinical practice under one or more approved collaborative practice agreements, and temporary or provisional approval does not count toward it.
The application also needs eight hours of controlled-substance prescribing instruction and four hours of advanced pharmacology completed within the year before applying, and the collaborating physician must hold a QACSC.
Until the certificate issues, a new CRNP prescribes legend drugs only.
What does a collaborating physician have to do in a CRNP's first two years?
For a CRNP with less than two years (4,000 hours) of collaborative practice experience — since initial certification, or in that physician's practice specialty — the physician must be present for not less than 10% of the CRNP's scheduled hours in the approved practice site.
Patient-home hours, hours in ADPH-licensed or ADMH-certified facilities, and hours under specified limited protocols are exempt.
Past two years, the rule states a meeting duty of no less than quarterly.
At every stage the physician visits remote practice sites at least twice a year and completes quarterly quality assurance with each CRNP.
No cap on CRNPs per physician appears in the rules read.
Do the DEA telehealth rules let an Alabama PMHNP prescribe stimulants remotely?
No. The DEA and HHS telemedicine flexibilities, extended through December 31, 2026, remove the federal in-person-evaluation requirement for registered practitioners, but they do not lift state limits.
Alabama's QACSC limits a CRNP to Schedules III, IV and V, and that schedule limit binds telehealth prescriptions the same as in-person ones, so Schedule II stimulants stay out of reach either way.
More Alabama & Psychiatric Nurse Practitioner Resources
Sources
- Ala. Admin. Code ch. 540-X-8 (Collaborative Practice) and ch. 540-X-18 (QACSC) — Alabama Board of Medical Examiners, via Cornell LII (retrieved 2026-09-24)
- Ala. Admin. Code r. 610-X-5-.08 and r. 610-X-5-.12 — Alabama Board of Nursing, collaborative practice rules, via Cornell LII (retrieved 2026-09-24)
- AANP, State Practice Environment (updated 05/2026) (retrieved 2026-09-24)
- DEA/HHS, Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities (90 FR 61301) (retrieved 2026-09-24)
Sourced from the statute, rules, board pages and other documents cited above.
Verified September 2026.
This is career information, not legal or clinical advice — confirm current rules with the Alabama Board of Nursing (with the Alabama Board of Medical Examiners).